BiotechTube

Ranolazine 500 MG + Ranolazine 1000 MG

Phase 2Completed
0 watching 0 views this week⚡ Active
51
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

ALS

Conditions

ALS

Trial Timeline

Jun 11, 2018 → Dec 9, 2022

NCT ID
NCT03472950

About Ranolazine 500 MG + Ranolazine 1000 MG

Ranolazine 500 MG + Ranolazine 1000 MG is a phase 2 stage product being developed by Gilead Sciences for ALS. The current trial status is completed. This product is registered under clinical trial identifier NCT03472950. Target conditions include ALS.

Hype Score Breakdown

Clinical
17
Activity
12
Company
9
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03472950Phase 2Completed

Competing Products

20 competing products in ALS

See all competitors
ProductCompanyStageHype Score
Oral Glycopyrrolate LiquidShionogiPhase 3
77
E0302 (mecobalamin)EisaiPhase 2/3
65
DonepezilEisaiApproved
85
E0302 (mecobalamin) + E0302 (mecobalamin) + PlaceboEisaiPhase 2/3
65
ONO-2506POOno PharmaceuticalPhase 2
52
ONO-2506PO + ONO-2506POOno PharmaceuticalPhase 2
52
LY4256984 + PlaceboEli LillyPhase 1
33
Racecadotril Film-Coated Tablet (FCT) + Racecadotril CapsuleJohnson & JohnsonPhase 1
33
UDI-001Rohto PharmaceuticalPhase 1/2
41
ABBV-8E12 + Placebo solution for IV infusion on Day 15AbbViePhase 2
52
Placebo + ABBV-8E12AbbViePhase 2
52
Fosigotifator + PlaceboAbbViePhase 1
33
ABBV-8E12AbbViePhase 1
33
antisense oligonucleotide + placeboNovartisPhase 1
33
VHB937NovartisPhase 2
52
Prednisolone + placebo + Valaciclovir + placebo + Prednisolone + valaciclovir + Placebo + placeboPfizerApproved
84
BMS-933043 + Placebo matching with BMS-933043 + Antacid Buffer Predose SolutionBristol Myers SquibbPhase 1
32
Rifabutin + Rifabutin + Atazanavir + RitonavirBristol Myers SquibbPhase 1
32
ALN-SOD + Placebo (PB)Regeneron PharmaceuticalsPhase 1/2
40
UCB0107 (bepranemab)UCBPhase 1
30

Other Products from Gilead Sciences

Ranolazine + PlaceboApproved
84
Truvada + Atazanavir + RitonavirApproved
84
Truvada + efavirenzApproved
84
B/F/TAF + Atripla + B/F/TAF Placebo + Atripla PlaceboApproved
84
TDF + Placebo Vaginal Gel + Vaginal TFV Gel + Placebo TabletsApproved
84